Who Should Own the Prescription for Digital Therapeutics?

Who Should Own the Prescription for Digital Therapeutics?
ap

Where should a digital health application pharmacy live: in a hospital, with payers, or retailers? Or should an FDA-like system be developed to validate and certify apps for the public to use?

In November, Mount Sinai Health System released RxUniverse allowing doctors to easily prescribe approved mHealth apps, personalized educational materials, patient satisfaction surveys, and other documents for their patients.

When I first read about the platform, I was impressed: Physicians and tech leaders at Mount Sinai worked for months to create a list of apps they believe will be most useful for their population, helping care providers and consumers parse through an oversaturated landscape of thousands of digital health apps. With this platform, they've finally provided a way for care providers to prescribe digital therapeutics. Right now, RxUniverse is only being used at Mount Sinai, but there are plans to offer the platform for use in other care organizations in 2017.



Comment
Show comments Hide Comments


Related Articles